Caris Life Sciences Inc., a healthcare company devoted to cancer diagnostics and treatment through technological advancements, is taking significant strides toward an Initial Public Offering (IPO) aiming to raise $423.5 million. Supported by investment powerhouse Sixth Street Partners, Caris is set to broaden its impact in the medical sector with this financial maneuver.

Hims & Hers Health Inc. $HIMS has taken a decisive step toward international growth by acquiring Zava, a private telemedicine provider with a strong foothold in Europe. The transaction grants Hims & Hers access to Zava’s 1.3 million active users and opens a clear path to offer its digital healthcare solutions across France, Germany, and Ireland. This move significantly accelerates the company's ability to serve a broader, diversified patient population within critical European markets.